1. Home
  2. PBYI vs EM Comparison

PBYI vs EM Comparison

Compare PBYI & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • EM
  • Stock Information
  • Founded
  • PBYI 2010
  • EM 2017
  • Country
  • PBYI United States
  • EM China
  • Employees
  • PBYI N/A
  • EM N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • PBYI Health Care
  • EM Consumer Discretionary
  • Exchange
  • PBYI Nasdaq
  • EM Nasdaq
  • Market Cap
  • PBYI 153.2M
  • EM 191.0M
  • IPO Year
  • PBYI N/A
  • EM 2021
  • Fundamental
  • Price
  • PBYI $3.09
  • EM $0.99
  • Analyst Decision
  • PBYI Strong Buy
  • EM Strong Buy
  • Analyst Count
  • PBYI 1
  • EM 1
  • Target Price
  • PBYI $7.00
  • EM $1.00
  • AVG Volume (30 Days)
  • PBYI 754.5K
  • EM 1.3M
  • Earning Date
  • PBYI 02-27-2025
  • EM 01-21-2025
  • Dividend Yield
  • PBYI N/A
  • EM N/A
  • EPS Growth
  • PBYI 492.79
  • EM N/A
  • EPS
  • PBYI 0.47
  • EM 0.03
  • Revenue
  • PBYI $243,569,000.00
  • EM $269,745,696.00
  • Revenue This Year
  • PBYI N/A
  • EM N/A
  • Revenue Next Year
  • PBYI N/A
  • EM $6.16
  • P/E Ratio
  • PBYI $6.63
  • EM $30.26
  • Revenue Growth
  • PBYI 6.30
  • EM N/A
  • 52 Week Low
  • PBYI $2.23
  • EM $0.43
  • 52 Week High
  • PBYI $7.73
  • EM $1.18
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 49.17
  • EM 78.21
  • Support Level
  • PBYI $2.92
  • EM $0.68
  • Resistance Level
  • PBYI $4.06
  • EM $1.02
  • Average True Range (ATR)
  • PBYI 0.29
  • EM 0.05
  • MACD
  • PBYI 0.01
  • EM 0.03
  • Stochastic Oscillator
  • PBYI 27.07
  • EM 83.78

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.

Share on Social Networks: